Gender Differences in Statin Prescription Rate Among Patients Living With HIV and Hepatitis C Virus.
作者信息
Al-Kindi Sadeer G, Zidar David A, McComsey Grace A, Longenecker Chris T
机构信息
Harrington Heart and Vascular Institute, University Hospitals Case Medical Center and School of Medicine.
Division of Infectious Diseases, Rainbow Babies and Children's Hospital and School of Medicine, Case Western Reserve University, Cleveland, Ohio.
出版信息
Clin Infect Dis. 2016 Oct 1;63(7):993-4. doi: 10.1093/cid/ciw448. Epub 2016 Jul 1.
Abstract
摘要
相似文献
1
Gender Differences in Statin Prescription Rate Among Patients Living With HIV and Hepatitis C Virus.感染艾滋病毒和丙型肝炎病毒患者中他汀类药物处方率的性别差异
Clin Infect Dis. 2016 Oct 1;63(7):993-4. doi: 10.1093/cid/ciw448. Epub 2016 Jul 1.
2
Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?他汀类药物在丙型肝炎相关肝硬化患者中的应用：真实益处还是不朽时间偏倚？
Gastroenterology. 2016 Aug;151(2):373. doi: 10.1053/j.gastro.2015.11.055. Epub 2016 Jul 1.
3
Statins and risk of decompensation in hepatitis B virus-related and hepatitis C virus-related cirrhosis: Methodological issues.他汀类药物与乙型肝炎病毒相关和丙型肝炎病毒相关肝硬化失代偿风险：方法学问题。
Hepatology. 2018 Mar;67(3):1174. doi: 10.1002/hep.29687. Epub 2018 Jan 30.
4
Fibrosis progression in chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus.人类免疫缺陷病毒和丙型肝炎病毒合并感染患者慢性丙型肝炎中的纤维化进展
Rev Soc Bras Med Trop. 2016 Nov-Dec;49(6):806-807. doi: 10.1590/0037-8682-0392-2016.
5
3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.3-羟基-3-甲基戊二酰辅酶 A 还原酶抑制剂在慢性肝病中的应用：一个治疗争议。
J Clin Lipidol. 2011 Nov-Dec;5(6):450-9. doi: 10.1016/j.jacl.2011.06.013. Epub 2011 Jun 28.
6
Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection.他汀类药物的使用与丙型肝炎病毒感染患者肝硬化发展的风险。
J Hepatol. 2015 Nov;63(5):1111-7. doi: 10.1016/j.jhep.2015.07.006. Epub 2015 Jul 18.
7
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.他汀类药物与丙型肝炎相关代偿期肝硬化退伍军人失代偿和死亡风险降低相关。
Gastroenterology. 2016 Feb;150(2):430-40.e1. doi: 10.1053/j.gastro.2015.10.007. Epub 2015 Oct 17.
8
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.在丙型肝炎病毒患者中，阿托伐他汀和氟伐他汀与肝硬化和肝细胞癌的剂量依赖性降低相关：ERCHIVES研究结果。
Hepatology. 2016 Jul;64(1):47-57. doi: 10.1002/hep.28506. Epub 2016 Mar 25.
9
Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.丙型肝炎病毒与人类免疫缺陷病毒合并感染患者中慢性丙型肝炎向肝纤维化和肝硬化的进展。
Clin Infect Dis. 2003 Feb 15;36(4):491-8. doi: 10.1086/367643. Epub 2003 Jan 31.
10
Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.拉丁美洲和加勒比地区艾滋病毒/艾滋病感染者中丙型肝炎病毒的血清流行率：一项系统综述
BMC Infect Dis. 2016 Nov 9;16(1):663. doi: 10.1186/s12879-016-1988-y.
引用本文的文献
1
Virtual adaptation of a nurse-driven strategy to improve blood pressure control among people with HIV.一种由护士主导的策略的虚拟适应性调整，以改善艾滋病毒感染者的血压控制。
HIV Res Clin Pract. 2025 Dec;26(1):2477396. doi: 10.1080/25787489.2025.2477396. Epub 2025 Mar 18.
2
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.感染HIV且心血管风险为低/中度至高度人群中他汀类药物处方的性别差异
Open Forum Infect Dis. 2024 Sep 9;11(9):ofae502. doi: 10.1093/ofid/ofae502. eCollection 2024 Sep.
3
The Impact of Regular Screening and Lifestyle Modification on Cardiovascular Disease Risk Factors in South African Women Living With HIV.定期筛查和生活方式改变对南非 HIV 感染者心血管疾病危险因素的影响。
J Acquir Immune Defic Syndr. 2024 May 1;96(1):23-33. doi: 10.1097/QAI.0000000000003387. Epub 2024 Apr 10.
4
Development of text messages for primary prevention of cardiovascular disease in persons with HIV.为艾滋病毒感染者进行心血管疾病一级预防而开发短信。
Cardiovasc Digit Health J. 2023 Nov 8;4(6):191-197. doi: 10.1016/j.cvdhj.2023.11.002. eCollection 2023 Dec.
5
Cardiovascular health among persons with HIV without existing atherosclerotic cardiovascular disease.HIV 感染者的心血管健康：无现有动脉粥样硬化性心血管疾病。
AIDS. 2023 Nov 15;37(14):2179-2183. doi: 10.1097/QAD.0000000000003666. Epub 2023 Jul 26.
6
Statin Utilization Among Individuals Infected With Hepatitis C Virus: A Retrospective Cohort Study.丙型肝炎病毒感染个体的他汀类药物使用情况：一项回顾性队列研究
Cureus. 2023 Mar 12;15(3):e36049. doi: 10.7759/cureus.36049. eCollection 2023 Mar.
7
Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation.他汀类药物在 HIV 成人患者中的应用：治疗差距及他汀类药物起始治疗的预测因素。
J Acquir Immune Defic Syndr. 2022 Dec 15;91(5):469-478. doi: 10.1097/QAI.0000000000003083.
8
Statin-induced Liver Injury Patterns: A Clinical Review.他汀类药物所致肝损伤模式：一项临床综述
J Clin Transl Hepatol. 2022 Jun 28;10(3):543-552. doi: 10.14218/JCTH.2021.00271. Epub 2022 Jan 10.
9
Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).基于护士主导的干预措施以扩大心血管疾病预防试验（EXTRA-CVD）中 HIV 治疗环节的理由和设计。
Am Heart J. 2019 Oct;216:91-101. doi: 10.1016/j.ahj.2019.07.005. Epub 2019 Jul 18.
10
Vascular disease and aging in HIV: Time to extend the treatment cascade.HIV 中的血管疾病与衰老：是时候扩展治疗流程了。
Vasc Med. 2018 Oct;23(5):476-477. doi: 10.1177/1358863X18789767. Epub 2018 Aug 13.
本文引用的文献
1
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study.HIV和HCV感染退伍军人中他汀类药物的使用情况及建议：一项队列研究
Clin Infect Dis. 2016 Aug 1;63(3):407-13. doi: 10.1093/cid/ciw289. Epub 2016 May 3.
2
Prevalence of Cholesterol Treatment Eligibility and Medication Use Among Adults--United States, 2005-2012.胆固醇治疗适宜性和药物使用在成年人中的流行率——美国，2005-2012 年。
MMWR Morb Mortal Wkly Rep. 2015 Dec 4;64(47):1305-11. doi: 10.15585/mmwr.mm6447a1.
3
Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data.与静脉血栓栓塞事件相关的患者特征：使用汇总电子健康记录数据的队列研究。
J Am Med Inform Assoc. 2012 Nov-Dec;19(6):965-72. doi: 10.1136/amiajnl-2011-000782. Epub 2012 Jul 3.
Zotero 插件